|
Guido Smeets, MD, Vice President of Clinical Research and Chief Medical Officer, joined VNUS in 2008 with nearly 20 years of clinical research experience. Dr. Smeets previously served as the Head of Clinical Affairs for Pelikan Technologies, Inc., a privately held diagnostic testing platform company. Prior to Pelikan Technologies, he was Vice President of Clinical Development for Ilypsa, Inc. and for GMP Companies, Inc. Dr. Smeets held increasingly responsible positions in Clinical Research at Mallinckrodt, Inc., as well as in Sales and Marketing at Johnson & Johnson and Mallinckrodt BV. Dr. Smeets holds a Doctor of Medicine from Utrecht University, School of Medicine, The Netherlands and an MBA from Erasmus University, Rotterdam School of Management, The Netherlands. | 